AS
Andrew J. Schwab

Andrew J. Schwab insider trades: Skye Bioscience (SKYE) stock buys and sales

Skye Bioscience Last trade Sep 23, 2026 104 Form 4 filings
$5.9M
Sold, last 12 months
13 sales
$0
Bought, last 12 months
0 buys
104
Open-market trades
since 2014
26
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Andrew reports to the SEC

and 20 more companies

Open-market buys and sales

104 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 23, 2026SKYE↓ Sell$230K
Sep 23, 2026SKYE↓ Sell$9K
Sep 16, 2026SKYE↓ Sell$62K
Sep 16, 2026SKYE↓ Sell$2K
Aug 27, 2026CAMP↓ Sell$1.6M
Aug 24, 2026CAMP↓ Sell$45
Aug 21, 2026CAMP↓ Sell$880K
Aug 20, 2026SKYE↓ Sell$118K
Aug 20, 2026SKYE↓ Sell$21K
Aug 20, 2026SKYE↓ Sell$853
Aug 7, 2026TRDA↓ Sell$432K
Jul 31, 2026TRDA↓ Sell$807K
Nov 14, 2025TRDA↓ Sell$1.8M
Aug 22, 2025SKYE↓ Sell$770K
Aug 22, 2025SKYE↓ Sell$30K
Jul 9, 2025TRDA↓ Sell$151K
Jul 9, 2025TRDA↓ Sell$52K
Jul 1, 2025TRDA↓ Sell$644K
Jul 1, 2025TRDA↓ Sell$223K
Oct 15, 2024CAMP↑ Buy$10.0M
Sep 13, 2024SKYE↓ Sell$1.5M
Sep 13, 2024SKYE↓ Sell$253K
Sep 13, 2024SKYE↓ Sell$10K
Jul 22, 2024ARTV↑ Buy$10.0M
Feb 14, 2024ELVN↓ Sell$10.3M
Feb 14, 2024ELVN↓ Sell$2.0M
Jan 31, 2024ELVN↓ Sell$6.3M
Jan 31, 2024ELVN↓ Sell$1.2M
Sep 26, 2023ELVN↓ Sell$2.5M
Sep 26, 2023ELVN↓ Sell$491K
Aug 24, 2023ELVN↓ Sell$5.9M
Aug 24, 2023ELVN↓ Sell$1.2M
Apr 10, 2023PEAR↓ Sell$1.5M
Apr 10, 2023PEAR↓ Sell$381K
Apr 10, 2023PEAR↓ Sell$64K
Mar 7, 2023RLYB↓ Sell$820K
Nov 15, 2022PEAR↓ Sell$277K
Nov 15, 2022PEAR↓ Sell$12K
Nov 2, 2022PEAR↓ Sell$144K
Nov 2, 2022PEAR↓ Sell$6K
Oct 10, 2022SCPH↓ Sell$2.0M
Oct 10, 2022SCPH↓ Sell$385K
Oct 10, 2022SCPH↓ Sell$84K
Sep 16, 2022PEAR↓ Sell$1.0M
Sep 16, 2022PEAR↓ Sell$42K
Sep 8, 2022PEAR↓ Sell$1.5M
Sep 8, 2022PEAR↓ Sell$63K
Sep 7, 2022SCPH↓ Sell$894K
Sep 7, 2022SCPH↓ Sell$165K
Sep 7, 2022SCPH↓ Sell$37K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SKYE insiders

Open-market trades in the last 12 months

About Andrew J. Schwab's insider trades

Andrew J. Schwab is an insider at Skye Bioscience (SKYE). Since Sep 23, 2014, Andrew has reported 23 open-market purchases worth $123.3M and 81 sales worth $204.6M on SEC Form 4. In the last 12 months: 13 sales ($5.9M).

Their filings also include grants and awards (18 filings), conversions (17 filings), other transactions (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SKYE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.